Your Complete Wegovy Dose Journey Starts Here
Can I Switch From Mounjaro To Wegovy? Understanding Your Complete Dose Options
The decision to switch from Mounjaro to Wegovy requires careful consideration of each treatment's unique mechanisms and dosing protocols. Mounjaro contains tirzepatide, which targets both GIP and GLP-1 receptors, whilst Wegovy uses semaglutide to specifically activate GLP-1 receptors in your brain's appetite control centres. At EverydayMeds, we maintain comprehensive stock of all five Wegovy doses, ensuring patients who choose to transition can complete their entire treatment journey without supply interruptions. This complete dose availability means you'll never need to source different strengths from multiple pharmacies, providing consistency and continuity throughout your weight management programme.
When patients ask "can I switch from Mounjaro to Wegovy", the practical answer depends on clinical suitability and individual response patterns. Both treatments require mandatory dose escalation protocols, though Wegovy's pathway follows a specific 17-week escalation from 0.25mg through to 2.4mg maintenance dosing. Our prescribers evaluate your current Mounjaro experience, any side effects encountered, and your weight management goals to determine optimal transition timing. Having all doses readily available allows for flexible prescribing decisions, whether you need to start from the beginning with 0.25mg or require a different entry point based on your clinical history.
Wegovy Pricing Structure: From Starter To Maintenance Doses
Understanding the complete cost pathway when you switch from Mounjaro to Wegovy helps in making informed treatment decisions. Individual Wegovy pens are priced at £79.99 for 0.25mg starter dose, £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. New customers benefit from discount code FIRST40 applied at checkout to reach these final prices, whilst returning customers use code DOSE25. Our Getting Started bundles provide convenience for dose transitions, such as the Intro Duo combining 0.25mg and 0.5mg pens for £169.99, or the Progress Trio including 0.5mg, 1mg and 1.7mg doses for £369.99.
For patients reaching maintenance phase, our Ultimate Stability Trio provides three months of 2.4mg supply for £649.99, eliminating the need for monthly reordering. The Consistency bundles offer two pens of the same strength for patients requiring extended time on particular doses, such as Consistency 1mg for £209.99 or Consistency 2.4mg for £419.99. This comprehensive pricing structure means patients considering whether they can switch from Mounjaro to Wegovy can plan their complete treatment costs from initiation through long-term maintenance dosing.
Clinical Evidence Supporting Wegovy In Weight Management
The STEP clinical trial programme provides robust evidence for patients evaluating whether they can switch from Mounjaro to Wegovy based on efficacy data. In the pivotal STEP 1 trial, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo, as reported by Wilding et al. in the New England Journal of Medicine, 2021. STEP 2 demonstrated that patients with type 2 diabetes achieved around 9.6% weight reduction, whilst STEP 3 showed approximately clinically studied weight loss when combined with intensive behavioural therapy.
Long-term sustainability data from STEP 5 indicated maintained weight loss of approximately 15.2% at two years, addressing common concerns about treatment durability. The recent SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major cardiovascular events, expanding Wegovy's clinical value beyond weight management alone. These comprehensive trial results provide evidence-based context for prescribers counselling patients who ask whether they can switch from Mounjaro to Wegovy.
How Wegovy Works: GLP-1 Mechanism For Appetite Control
Understanding Wegovy's mechanism helps explain why patients might consider switching from Mounjaro to Wegovy based on different receptor targeting approaches. Wegovy contains semaglutide, which specifically mimics the GLP-1 hormone naturally produced in your intestines after eating. This prescription-only medicine works by binding to GLP-1 receptors in brain regions controlling appetite and food reward pathways, potentially reducing overall caloric intake through enhanced satiety signals. The once-weekly injection provides sustained hormone activity, helping maintain consistent appetite modulation throughout the week. Unlike Mounjaro's dual receptor approach, Wegovy focuses solely on GLP-1 pathways, which may suit patients who respond well to this specific mechanism or experience particular side effect profiles with dual agonist treatments.
Streamlined Ordering: Assessment To Delivery
Patients ready to switch from Mounjaro to Wegovy can begin with our streamlined 3-minute online clinical assessment, designed to capture relevant medical history, current medications, and treatment goals. Our GPhC-registered prescribers (#9012878) review applications within standard 3 working days, or via express 24-hour service for urgent requirements. Once approved, all Wegovy doses ship via next-day delivery using temperature-controlled cold-chain logistics to maintain pharmaceutical integrity. The process includes comprehensive treatment guidance, dose escalation schedules, and ongoing clinical support throughout your treatment journey. This integrated approach means switching from one treatment to another involves minimal disruption whilst ensuring appropriate clinical oversight and medication continuity.
Storage Advantages And Practical Considerations
One practical factor when patients evaluate whether they can switch from Mounjaro to Wegovy involves storage and handling differences between treatments. Wegovy offers superior storage flexibility, remaining stable at room temperature below 30°C for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This extended stability benefits frequent travellers or patients with variable refrigeration access. The FlexTouch pen delivery system provides consistent dosing with clear dose windows and intuitive operation. Wegovy's mandatory dose escalation protocol requires starting at 0.25mg regardless of previous Mounjaro dosing, allowing your system to adjust gradually to semaglutide's specific GLP-1 effects. Having all escalation doses readily available ensures smooth transitions without treatment gaps that could compromise therapeutic momentum.
Seamless Treatment Transition: Why Complete Dose Availability Matters
The question "can I switch from Mounjaro to Wegovy" becomes practically straightforward when your pharmacy stocks every required dose from initiation through maintenance. Treatment interruptions due to dose unavailability can compromise weight management progress and may necessitate restarting escalation protocols, potentially extending overall treatment timelines. At EverydayMeds, maintaining comprehensive Wegovy inventory from 0.25mg starter through 2.4mg maintenance ensures patients transitioning from alternative treatments can maintain therapeutic momentum without supply-related delays.
This complete dose availability particularly benefits patients who may need flexible escalation timing based on individual tolerability or response patterns. Some patients require extended periods on intermediate doses before progressing, whilst others may need to temporarily step down if side effects emerge. Having immediate access to all strength options allows prescribers to optimise individual treatment pathways rather than being constrained by limited stock availability, ultimately supporting better long-term treatment adherence and clinical outcomes.
Start Your Wegovy Journey: Complete Dose Coverage Available Now
Patients ready to switch from Mounjaro to Wegovy can confidently begin knowing all required doses are immediately available through our GPhC-registered pharmacy (#9012878). Whether you need individual pens or prefer bundle convenience, our comprehensive pricing structure accommodates different treatment phases from initial escalation through long-term maintenance. New customers apply discount code FIRST40 at checkout, whilst returning customers use DOSE25 to access our competitive pricing. Our clinical team provides ongoing support throughout your treatment transition, ensuring optimal therapeutic outcomes whether you're switching treatments or beginning weight management therapy. Visit https://everydaymeds.co.uk/collections/wegovy to start your assessment and secure your complete Wegovy supply today. This prescription-only medicine, alongside a reduced-calorie diet and increased physical activity, may support your weight management goals with the confidence of uninterrupted supply availability.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
